摘要
目的介绍2015年以来美国FDA批准的孤儿药。方法查阅近年来国内外相关文献,对其进行分析和归纳总结。结果孤儿药在抗肿瘤、抗代谢病、抗菌、抗高血压以及其他领域发展迅速。结论孤儿药发展迅速,随着精准医疗的发展,孤儿药具有良好的开发前景。
Objective To introduce the orphan drugs approved by FDA since 2015. Methods Analyze and summarize combining with related literatures. Results The orphan drugs have developed rapidly in the domains of antineoplastic, anti-metabolic, anti-microbial, anti-hypertension and others. Conclusions The orphan drugs grow quickly and have a favorable development prospect.
出处
《沈阳药科大学学报》
CSCD
北大核心
2017年第6期526-534,共9页
Journal of Shenyang Pharmaceutical University
基金
国家基础学科人才培养基金资助项目(J1103606)
关键词
FDA
孤儿药
进展
food and drug administration
the orphan drugs
progress
